Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...

Given that only about 1 in 4 eligible individuals currently receive housing assistance, a potential benefit of extending housing assistance may be earlier-stage diagnoses of these cancers,” ...

CRT consisted of concomitant cisplatin (3 doses of 100 mg/m 2 every 3 weeks or 7 doses of 40 mg/m 2 every week) and radiotherapy (70 Gy in 35 fractions). A single dose of durvalumab (1500 mg) was ...

Disitamab vedotin plus toripalimab improved progression-free survival and overall survival when compared to chemotherapy.

Consistently reaching guidelines at moderate levels over three decades associated with significant reduction in DSC risk.

Sevabertinib produced “robust and durable” responses in patients with HER2-mutant NSCLC, whether they were previously treated or untreated in the advanced setting, according to Xiuning Le, MD, PhD.

Researchers sought to determine whether survival outcomes for patients with early breast cancer was better with NACT or ACT when pCR was not achieved.

Researchers sought to determine whether zanubrutinib would be effective for patients with CLL/SLL who were intolerant to other BTK inhibitors.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

A systematic review with meta-analysis compared single- versus multi-port robotic approaches in prostate and renal surgery.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

A study on oncology care models demonstrates the potential of nurse practitioners to lead multidisciplinary oncologic care teams.